Lissun raised ₹48 crore in a Series A led by Colossa Ventures, with Physis Capital and existing backers including RPSG Capital Ventures, Ivycap Ventures and Rainmatter participating.
The capital is earmarked for expanding Sunshine by LISSUN child development centres, building AI-led tools and strengthening clinical processes.
It is Lissun's largest disclosed round, following a $1.3 million seed (2023), a $2.5 million pre-Series A (2024) and a ₹2.77 crore tranche in June 2026.
Growth and session figures are company-stated and unaudited, and a centre-led therapy model scales cost with each new location rather than at software margins.
Read the full story on StartupFox